Target intelligence / Profile preview

Aldehyde dehydrogenase 2 (mitochondrial) (ALDH2)

Target
ALDH2
Molecular classification
Enzyme, Oxidoreductase, Mitochondrial protein
01

Overview

Aldehyde dehydrogenase 2 (mitochondrial) is a tetrameric enzyme located in the mitochondrial matrix, encoded by the ALDH2 gene on chromosome 12[1][5]. It catalyzes the oxidation of acetaldehyde (a toxic intermediate in alcohol metabolism) to acetic acid, with a low Km for acetaldehyde, making it essential in alcohol detoxification[1]. ALDH2 plays a protective role against toxic aldehydes, prevents DNA damage in hematopoietic stem cells, and participates in broader aldehyde metabolism[2]. Genetic variants, particularly common in East Asian populations, lead to ALDH2 enzyme deficiency, resulting in alcohol flush reaction and increasing risks of certain cancers and cardiovascular diseases[1][6]. ALDH2 is also targeted by drugs such as disulfiram (for alcohol aversion) and ALDH2 activators (targeting aldehyde toxicity), and is being investigated as a prognostic and pharmacogenetic biomarker in cancer and cardiovascular disease[4][6].

Other names
Aldehyde dehydrogenase 2 family memberALDH2ALDH-E2ALDHIALDMALDH2 family (mitochondrial)
02

Mechanism of action

Inhibition leads to acetaldehyde accumulation (disulfiram in alcohol aversion therapy) Activation enhances detoxification of toxic aldehydes

03

Biological functions

Detoxification of acetaldehyde (a toxic metabolite of ethanol)Protection against formaldehyde toxicityRegulation of hematopoietic stem cell function and DNA integrityMetabolism of endogenous and exogenous aldehydes
04

Disease associations

CancerCardiovascular diseaseAlcohol sensitivity and flushingPulmonary hypertensionNeurodegenerative diseaseHematologic malignancies (e.g. acute leukemia)
05

Safety considerations

Adverse reactions with alcohol (especially in individuals with ALDH2*2 allele)Flushing, nausea, tachycardia with alcohol plus disulfiram or in deficient genotypeIncreased cancer and cardiovascular risk with ALDH2 deficiency
06

Interacting drugs

Disulfiram

2 more in the full profile.

07

Biomarkers

rs671 polymorphism for alcohol flushing and disease risk stratificationPrognostic marker in head and neck squamous cell carcinoma and possibly leukemia

Beyond the preview

Go deeper on Aldehyde dehydrogenase 2 (mitochondrial) (ALDH2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aldehyde dehydrogenase 2 (mitochondrial) (ALDH2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call